Evidence map›Paper›PMID 36283989›Full record

ArticleCellular and molecular life sciences : CMLS2022

Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system.

Sanpreet Singh, Sudeep K Maurya, Mohammad Aqdas, Hilal Bashir, Ashish Arora, Vijayender Bhalla, Javed N Agrewala

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Recent Characterization of Key Proteins to Combat Tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. F18 Promiscuous Epitope of Acr1 Protein ofProtein and peptide letters · 2025
    Article
  12. TowardMicroorganisms · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sanpreet SinghImmunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India.
Sudeep K MauryaImmunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India.
Mohammad AqdasImmunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India.
Hilal BashirImmunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India.
Ashish AroraDepartment of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Vijayender BhallaImmunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India.
Javed N AgrewalaImmunology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh, 160036, India. jagrewala@gmail.com.ORCID http://orcid.org/0000-0003-0227-1042
Institute of Microbial Technology · INCentral Drug Research Institute · INIndian Institute of Technology Ropar · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) is a smart and successful pathogen since it can persist in the intimidating environment of the host by taming and tuning the immune system. Mtb releases MPT64 (Rv1980c) protein in high amounts in patients with active tuberculosis (TB). Consequently, we were curious to decipher the role of MPT64 on the differentiating dendritic cells (DCs) and its relation to evading the immune system. We observed that pre-exposure of differentiating DCs to MPT64 (DC

Indexed as

Mycobacterium tuberculosisMyeloid-Derived Suppressor CellsArginaseB7-H1 AntigenCytokinesDendritic CellsGlucoseHepatitis A Virus Cellular Receptor 2Interleukin-10Interleukin-12Interleukin-6LipidsNitric OxidePyruvaldehydeReceptors, CCR7Th1 CellsArginaseB7-H1 AntigenCytokinesGlucoseHepatitis A Virus Cellular Receptor 2Interleukin-10Interleukin-12Interleukin-6LipidsNitric OxidePyruvaldehydeReceptors, CCR7Transforming Growth Factor betaTumor Necrosis Factor-alphaDendritic cellsMDSCsMtbTregs

Identifiers

PMID36283989
PMCPMC11803053
OpenAlexW4307223452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.